Earnings History Data for Perspective Therapeutics, Inc. (CATX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Perspective Therapeutics, Inc.
Perspective Therapeutics Inc. is a medical technology and radiopharmaceutical company which provide advanced treatment applications for cancers. The Company is the sole producer of Cesium-131 brachytherapy seeds. Perspective Therapeutics Inc., formerly known as Isoray Inc., is based in RICHLAND, Wash.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12-08-2024 | AH | CATX | Perspective Therapeutics, Inc. | 823.36 | -0.17 | -0.21 | -0.40 | Perspective Therapeutics GAAP EPS of -$0.18 misses by $0.05, revenue of $0.53M beats by $0.39M [8/12/2024 4:34 PM] |
12.79 | 0.71 (5.83%) |
11.95 | -0.14 (-1.16%) |
2.05 - 19.05 | 607,949 | 570,000 | 621 | ||
| 15-05-2024 | PM | CATX | Perspective Therapeutics, Inc. | 1,030 | -0.02 | -0.03 | 0.00 | Perspective Therapeutics GAAP EPS of -$0.02, revenue of $0.33M [5/15/2024 7:03 AM] |
1.55 | -0.21 (-11.65%) |
1.75 | -0.01 (-0.57%) |
0.20 - 1.90 | 17,614,956 | 5,080,000 | 23,829 | ||
| 14-11-2023 | AH | CATX | Perspective Therapeutics, Inc. | 66.00 | -0.04 | -0.04 | 0.00 | Perspective Therapeutics GAAP EPS of -$0.04 in-line, revenue of $2.19M misses by $0.01M [11/14/2023 5:47 PM] |
0.2538 | 0.02 (9.40%) |
0.25 | 0.02 (7.80%) |
0.20 - 0.73 | 409,323 | 280,000 | 32,596 | ||
| 11-08-2023 | PM | CATX | Perspective Therapeutics, Inc. | 68.00 | -0.04 | -0.03 | 0.00 | Perspective Therapeutics GAAP EPS of -$0.04, revenue of $2.1M [8/11/2023 8:50 AM] |
0.4626 | -0.02 (-5.01%) |
0.47 | -0.02 (-3.37%) |
0.19 - 0.73 | 224,111 | 270,000 | 17,691 | ||